Terms: = Cervical cancer AND WHSC1, 7468, O96028, WHS, TRX5, REIIBP, NSD2, MMSET, MGC176638, KIAA1090, FLJ23286
4 results:
1. nsd2 inhibition suppresses metastasis in cervical cancer by promoting TGF-β/TGF-βRI/SMADs signaling.
Zhu L; Yu CL; Zheng Y
Biochem Biophys Res Commun; 2019 Nov; 519(3):489-496. PubMed ID: 31526565
[TBL] [Abstract] [Full Text] [Related]
2. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
3. Epigenetic activation of whsc1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
Yin Z; Sun Y; Ge S; Sun J
Oncol Rep; 2017 Apr; 37(4):2286-2294. PubMed ID: 28260054
[TBL] [Abstract] [Full Text] [Related]
4. Serum levels of angiogenin (ANG) in invasive cervical cancer and in cervical intraepithelial neoplasia (CIN).
Bodner-Adler B; Hefler L; Bodner K; Leodolter S; Frischmuth K; Kainz C; Mayerhofer K
Anticancer Res; 2001; 21(1B):809-12. PubMed ID: 11299848
[TBL] [Abstract] [Full Text] [Related]